Hyundai Solifenacin Succinate Tablet 10 mg

Adult dose

The usual recommended dose for adults (including the elderly) is 5mg once daily. If necessary, the dose may be increased to a maximum of 10mg once daily. This medicine may be taken with or without food and should be swallowed whole with water. No dose adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance>30ml/min). In patients with severe renal impairment (creatinine clearance≤30ml/min), administer with caution and do not exceed 5mg once daily. No dose adjustment is necessary for patients with mild hepatic impairment. In patients with moderate hepatic impairment (Child-Pugh Class B), administer with caution and do not exceed 5mg once daily. For patients taking ketoconazole or another strong CYP3A4 inhibitor (e.g., ritonavir, nelfinavir, itraconazole), limit the maximum daily dose to 5mg.

This medication should not be used in patients with certain diseases or conditions. For example, it should not be taken by patients with urinary retention symptoms or serious gastrointestinal problems, those with severe myasthenia gravis, glaucoma, those allergic to this medication, patients undergoing hemodialysis, and those with severe liver or kidney dysfunction. Additionally, it should be used with caution in patients at risk of urinary retention, those with a risk of gastrointestinal obstruction or decreased gastrointestinal motility, those with severe kidney or liver dysfunction, and patients who are on specific concurrent medications. Particularly, dosages should be limited in patients with impaired liver and kidney function, and caution should be exercised when taken with certain drugs. While taking this medication, side effects such as dry mouth, constipation, blurred vision, dyspepsia, urinary tract infection, dizziness, and fatigue may occur. In some patients, serious allergic reactions such as severe bowel obstruction or angioedema and anaphylaxis may occur, so any unusual symptoms should be reported to a healthcare professional immediately. This medication may cause heart rhythm problems in patients with arrhythmias or abnormal potassium levels, so patients at risk should be especially cautious. The effectiveness may be enhanced or side effects may increase when taken with other anticholinergic medications, and it may reduce the efficacy of medications that promote gastrointestinal motility. It can also interact with enzymes that metabolize drugs in the liver, requiring dose adjustments when taken with certain medications. Women who are pregnant or breastfeeding should be cautious when taking this medication, especially breastfeeding mothers, as it can be passed to breast milk and may affect the baby, so it is advisable to avoid its use. Safety and effectiveness have not been established in pediatric patients, so it should not be administered to them. In case of overdose, symptoms such as headaches, dry mouth, dizziness, drowsiness, and blurred vision may occur, and in severe cases, specific treatments may be required. If an overdose is suspected, it is essential to visit a medical institution immediately for appropriate treatment. During the use of this medication, driving or operating machinery may increase the risk of accidents due to symptoms such as drowsiness and blurred vision, so caution is advised.

• Dry mouth
• constipation
• blurred vision
• urinary retention
• dry eyes
• nausea
• dyspepsia
• abdominal pain
• vomiting
• urinary tract infection

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is best to store the medication at room temperature, not too hot or too cold, specifically between 1 and 30 degrees Celsius.

Appearance

Light pink round film-coated tablets

Package unit

100 tablets/PTP [10 tablets/PTP X 10]